Built to provide individualized treatments for patients with improved outcomes, Baysient develops SaaS, cloud-based software that provides medical providers with a full line of individual dosage-determination products.
Physicians can harness the power of iDose® and T3®, our innovative web-based applications, to obtain accurate dosing information for the drug Infliximab. This medication is commonly prescribed for various inflammatory disease conditions such as inflammatory bowel disease (IBD), Crohn’s disease (CD), and rheumatoid arthritis (RA), among others.
Experience the Benefits of iDose and T3
Utilizing iDose and T3, physicians can eliminate guesswork, reduce unwanted immunogenicity, and provide better clinical outcomes for their patients. Our applications are designed to recognize the unique nature of each patient, ensuring they receive the right amount of drug at the right time to maintain treatment efficacy.
Maximizing Ancillary Income with Correct CPT Codes
Utilizing the correct CPT codes with iDose or T3 can generate ancillary income with each use. However, navigating the complex world of medical billing and reimbursement can be challenging. That’s why we’ve developed our comprehensive Reimbursement Guide to assist physicians in this process.
The Baysient Reimbursement Guide: Your Key to Simplified Billing
Our Reimbursement Guide provides a matrix of requirements that coordinate ordering tests, analytical complexity, disease severity, and treatment risk. By following this guide, physicians can ensure they adhere to the appropriate billing and reimbursement procedures, making the process more manageable and efficient.
Download Our Reimbursement Guide Today
Download Baysient’s Reimbursement Guide now and unlock the full potential of iDose and T3. Equip your practice with the knowledge and tools necessary to streamline the reimbursement process and focus on what truly matters: improving your patients’ lives.